Phase I, multicentre, dose‐escalation trial of monotherapy with milatuzumab (humanized anti‐ CD 74 monoclonal antibody) in relapsed or refractory multiple myeloma
Year: 2013
Type: article
Study design: Clinical Trial
Source: British Journal of Haematology
DOI: 10.1111/bjh.12565
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2017357058
